Results 211 to 220 of about 1,030,576 (315)

Areas of High Biodiversity Value Evidenced by the Spatial Scaling of Phylogenetic Uniqueness. [PDF]

Ecol Lett
Baselga A, Martín-Devasa R, Gómez-Rodríguez C.   +2 more
europepmc   +1 more source

The Minimal Architecture of Distinguishability (ANAM): Generative A/B/G/N Structure, the Unique Minimal Transition, and the Emergence of Numerical Form

Alena Petina
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

ChemFM as a scaling law guided foundation model pre-trained on informative chemicals. [PDF]

Commun Chem
Cai F, Zacour K, Zhu T, Tzeng TR, Duan Y, Liu L, Pilla S, Li G, Luo F.   +8 more
europepmc   +1 more source

UNIQUE OPTIMAL TIME MOMENT IN EXPONENTIALLY-CONVEX-REWARD 1-BULLET PROGRESSIVE SILENT DUEL OF ICT INNOVATION LAUNCH

Vadim Romanuke
openalex   +1 more source

An Evaluation of a Unique Gatekeeper Training for Suicide Prevention of College Students: Demonstrating Effective Partnering within Student Affairs

, 2013
Lisa House, Joseph F. Lynch, Mary Bane
openalex   +2 more sources

Superficial temporal artery haemorrhage caused by neurophysiological monitoring: a unique MRI finding [PDF]

, 2017
Geoffrey W. Peitz, Wylan C. Peterson, Shaheryar Hafeez, Ramesh Grandhi   +3 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

A note on conservation laws with discontinuous flux and L 1 initial data. [PDF]

Mon Hefte Math
Karlsen KH, Mitrovic D.
europepmc   +1 more source

Additional file 1 of A unique combination of Generalised Pustular Psoriasis (GPP), Acrodermatitis Continua of Hallopeau (ACH), and psoriatic arthritis (both axial and peripheral) in a young male – a case-based review of literature

Ritasman Baisya, Sukdev Manna, Sneha Dhali   +2 more
openalex   +1 more source